PMID- 30574140 OWN - NLM STAT- MEDLINE DCOM- 20191002 LR - 20210129 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 9 DP - 2018 TI - Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement. PG - 2803 LID - 10.3389/fimmu.2018.02803 [doi] LID - 2803 AB - The aberrant expression of human endogenous retrovirus (HERV) elements of the HERV-W family has been associated with different diseases, including multiple sclerosis (MS). In particular, the expression of the envelope protein (Env) from the multiple sclerosis-associated retrovirus (MSRV), a member of HERV-W family and known for its potent proinflammatory activity, is repeatedly detected in the brain lesions and blood of MS patients. Furthermore, human herpesvirus 6 (HHV-6) infection has long been suspected to play a role in the pathogenesis of MS and neuroinflammation. We show here that both HHV-6A and stimulation of its receptor, transmembrane glycoprotein CD46, induce the expression of MSRV-Env. The engagement of extracellular domains SCR3 and SCR4 of CD46-Cyt1 isoform was required for MSRV-env transactivation, limiting thus the MSRV-Env induction to the CD46 ligands binding these domains, including C3b component of complement, specific monoclonal antibodies, and both infectious and UV-inactivated HHV-6A, but neither HHV-6B nor measles virus vaccine strain. Induction of MSRV-Env required CD46 Cyt-1 singling and was abolished by the inhibitors of protein kinase C. Finally, both membrane-expressed and secreted MSRV-Env trigger TLR4 signaling, displaying thus a proinflammatory potential, characteristic for this viral protein. These data expand the specter of HHV-6A effects in the modulation of the immune response and support the hypothesis that cross-talks between exogenous and endogenous viruses may contribute to inflammatory diseases and participate in neuroinflammation. Furthermore, they reveal a new function of CD46, known as an inhibitor of complement activation and receptor for several pathogens, in transactivation of HERV env genes, which may play an important role in the pathogenesis of inflammatory diseases. FAU - Charvet, Benjamin AU - Charvet B AD - International Centre for Infectiology Research, INSERM U1111, CNRS UMR5308, Ecole Normale Superieure de Lyon, University of Lyon, Lyon, France. AD - GeNeuro Innovation, Lyon, France. FAU - Reynaud, Josephine M AU - Reynaud JM AD - International Centre for Infectiology Research, INSERM U1111, CNRS UMR5308, Ecole Normale Superieure de Lyon, University of Lyon, Lyon, France. FAU - Gourru-Lesimple, Geraldine AU - Gourru-Lesimple G AD - International Centre for Infectiology Research, INSERM U1111, CNRS UMR5308, Ecole Normale Superieure de Lyon, University of Lyon, Lyon, France. FAU - Perron, Herve AU - Perron H AD - GeNeuro Innovation, Lyon, France. FAU - Marche, Patrice N AU - Marche PN AD - Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Universite Grenoble-Alpes, IAPC, La Tronche, France. FAU - Horvat, Branka AU - Horvat B AD - International Centre for Infectiology Research, INSERM U1111, CNRS UMR5308, Ecole Normale Superieure de Lyon, University of Lyon, Lyon, France. LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20181206 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (CD46 protein, human) RN - 0 (ERVFRD-1 protein, human) RN - 0 (Membrane Cofactor Protein) RN - 0 (Pregnancy Proteins) SB - IM MH - Cell Line, Tumor MH - *Endogenous Retroviruses/genetics/immunology/metabolism MH - *Herpesvirus 6, Human/immunology/metabolism MH - Humans MH - Inflammation/genetics/immunology/pathology/virology MH - *Membrane Cofactor Protein/immunology/metabolism MH - *Multiple Sclerosis/genetics/immunology/metabolism/virology MH - *Pregnancy Proteins/biosynthesis/genetics/immunology MH - Protein Domains MH - *Roseolovirus Infections/genetics/immunology/metabolism PMC - PMC6291489 OTO - NOTNLM OT - CD46 OT - HHV-6A OT - MSRV OT - TLR4 OT - human endogenous retrovirus OT - inflammation OT - multiple sclerosis EDAT- 2018/12/24 06:00 MHDA- 2019/10/03 06:00 PMCR- 2018/01/01 CRDT- 2018/12/22 06:00 PHST- 2018/08/02 00:00 [received] PHST- 2018/11/13 00:00 [accepted] PHST- 2018/12/22 06:00 [entrez] PHST- 2018/12/24 06:00 [pubmed] PHST- 2019/10/03 06:00 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2018.02803 [doi] PST - epublish SO - Front Immunol. 2018 Dec 6;9:2803. doi: 10.3389/fimmu.2018.02803. eCollection 2018.